date,title,source
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-17-18,MIT researchers among winners of prestigious Breakthrough Prize,American City Business Journals
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-18-18,Biogen to Present Data from Alzheimers Disease Portfolio at the 2018 Clinical Trials on Alzheimers Disease (CTAD) Meeting,GlobeNewswire
Oct-19-18,Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?,Zacks
Oct-19-18,Alkermes Boasts Strong Portfolio and Impressive Pipeline,Zacks
Oct-19-18,"Stocks making the biggest move premarket: PG, HON, F, VFC, HOG AMZN & more",CNBC
Oct-22-18,Biogen earnings: Its all about upcoming Alzheimers disease results,MarketWatch
Oct-22-18,Biogen Q3 Earnings Outlook,Benzinga
Oct-22-18,"Analysts wary of Biogen's strategy as earnings, Alzheimer's data loom",American City Business Journals
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,Biogen on Deck as Biotechs Face Make-or-Break Earnings Season,Bloomberg
Oct-23-18,Edited Transcript of BIIB earnings conference call or presentation 23-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-23-18,Biogen Inc (BIIB) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-23-18,Biogen Earnings: 10 Highlights From BIIBs Q3,InvestorPlace
Oct-23-18,"Stocks - Caterpillar, 3M Tank in Pre-market; McDonalds, Verizon Gain",Investing.com
Oct-23-18,Biogen's Spinraza drives third-quarter profit beat,Reuters
Oct-23-18,Biogen's Spinraza drives third-quarter profit beat,Reuters
Oct-23-18,"Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines",Zacks
Oct-23-18,Biogen stock rises 3% after Q3 profit and revenue beats,MarketWatch
Oct-23-18,"Biogen Inc Earnings, Revenue beat in Q3",Investing.com
Oct-23-18,Biogen (BIIB) Q3 Earnings & Sales Beat Estimates,Zacks
Oct-23-18,[$$] Biogen 3Q Profit Rises 18%,The Wall Street Journal
Oct-23-18,"Biogen, UCB study of lupus treatment fails primary endpoint",MarketWatch
Oct-23-18,Biogen third-quarter profit rises 17.8 pct,Reuters
Oct-23-18,"Stoke CEO weighs clinical trials, IPO and partnerships after $90M round",American City Business Journals
Oct-23-18,UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus,GlobeNewswire
Oct-24-18,Biogen Rides the Spinraza Wave to Double-Digit Growth,Motley Fool
Oct-24-18,Alkermes Makes Financial Progress as Its Pipeline Moves Forward,Motley Fool
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Edited Transcript of BIIB earnings conference call or presentation 23-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
